1. Home
  2. AGYS vs BEAM Comparison

AGYS vs BEAM Comparison

Compare AGYS & BEAM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Agilysys Inc.

AGYS

Agilysys Inc.

HOLD

Current Price

$106.83

Market Cap

3.1B

Sector

Technology

ML Signal

HOLD

Logo Beam Therapeutics Inc.

BEAM

Beam Therapeutics Inc.

HOLD

Current Price

$27.75

Market Cap

3.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
AGYS
BEAM
Founded
1963
2017
Country
United States
United States
Employees
N/A
N/A
Industry
EDP Services
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.1B
3.0B
IPO Year
1994
2019

Fundamental Metrics

Financial Performance
Metric
AGYS
BEAM
Price
$106.83
$27.75
Analyst Decision
Buy
Buy
Analyst Count
4
12
Target Price
$111.67
$50.75
AVG Volume (30 Days)
356.4K
2.7M
Earning Date
05-18-2026
05-06-2026
Dividend Yield
N/A
N/A
EPS Growth
67.07
82.31
EPS
1.37
N/A
Revenue
$319,312,000.00
$24,000.00
Revenue This Year
$17.65
N/A
Revenue Next Year
$14.36
$33.77
P/E Ratio
$80.64
N/A
Revenue Growth
15.85
33.33
52 Week Low
$61.50
$15.60
52 Week High
$144.82
$38.26

Technical Indicators

Market Signals
Indicator
AGYS
BEAM
Relative Strength Index (RSI) 59.41 34.36
Support Level $103.30 $26.96
Resistance Level $114.25 $29.68
Average True Range (ATR) 4.41 2.45
MACD -0.71 -0.95
Stochastic Oscillator 44.96 5.82

Price Performance

Historical Comparison
AGYS
BEAM

About AGYS Agilysys Inc.

Agilysys Inc is engaged in hospitality software, delivering cloud-native SaaS and on-premise solutions for hotels, multi-amenity resorts, cruise lines, casinos, corporate foodservice management, restaurants, universities, stadiums, and healthcare facilities. The Company's software solutions include point-of-sale (POS), property management (PMS), inventory and procurement, payments, and related applications that manage and enhance the entire guest journey. It operates across the Americas, Europe, the Middle East, Africa, Asia-Pacific, and India with headquarters located in Alpharetta, GA. The Company has one reportable segment serving the global hospitality industry.

About BEAM Beam Therapeutics Inc.

Beam Therapeutics Inc is a biotechnology company committed to creating a new class of precision genetic medicines based on its proprietary base editing technology, with a vision of providing lifelong cures to patients suffering from serious diseases. The company is focused on its programs in the hematology and genetic disease portfolios, which comprise different product candidates in its pipeline, such as BEAM-101, which is being developed to target Sickle Cell Disease, BEAM-302, a liver-targeting lipid nanoparticle, being developed to target Alpha-1 antitrypsin deficiency, and other drug candidates including BEAM-302, BEAM-103 & 104. The company operates and manages its business in one operating segment, United States.

Share on Social Networks: